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Although substantial fecal shedding is expected to start years after initial infection with Mycobacterium avium
subspecies paratuberculosis (MAP), the potential for shedding by calves and therefore calf-to-calf transmission is
underestimated in current Johne’s disease (JD) control programs. Shedding patterns were determined in this study
in experimentally infected calves. Fifty calves were challenged at 2 weeks or at 3, 6, 9 or 12 months of age (6 calves
served as a control group). In each age group, 5 calves were inoculated with a low and 5 with a high dose of MAP.
Fecal culture was performed monthly until necropsy at 17 months of age. Overall, 61% of inoculated calves, representing
all age and dose groups, shed MAP in their feces at least once during the follow-up period. Although most calves shed
sporadically, 4 calves in the 2-week and 3-month high dose groups shed at every sampling. In general, shedding peaked
2 months after inoculation. Calves inoculated at 2 weeks or 3 months with a high dose of MAP shed more frequently than
those inoculated with a low dose. Calves shedding frequently had more culture-positive tissue locations and more severe
gross and histological lesions at necropsy. In conclusion, calves inoculated up to 1 year of age shed MAP in their feces
shortly after inoculation. Consequently, there is potential for MAP transfer between calves (especially if they are group
housed) and therefore, JD control programs should consider young calves as a source of infection.Introduction
Paratuberculosis or Johne’s disease (JD) is a chronic en-
teritis of ruminants caused by Mycobacterium avium
subspecies paratuberculosis (MAP) [1]. The disease is
widespread in dairy herds worldwide and causes sub-
stantial economic losses [2,3], due to reduced milk yield
[4,5], premature culling and reduced slaughter value
[6,7]. If not culled before clinical signs appear after a
long incubation period (years) [8], cattle suffer from
chronic, non-treatable diarrhea which leads to cachexia
and ultimately culling or death [1]. The primary route of
MAP transmission is fecal-oral, usually through inges-
tion of water, milk, or feed, contaminated by ruminants
shedding MAP in their feces [1].
Poor manure management, a contaminated environment
for calves, and contact with a shedding dam are the main
sources of MAP infection on a farm [9–11]. Therefore, JD
control programs involve 2 main objectives: reduce the* Correspondence: jdebuck@ucalgary.ca
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unless otherwise stated.number of infected animals that are shedding MAP, and
prevent fecal-oral transmission by implementing best-
hygiene practices for newborn calves [7]. Although research
studies have described associations between management
practices and the probability of cattle being infected with
MAP [12–14], specific questions remain unanswered. In
particular, the potential of calves shedding and contaminat-
ing the environment, as well as the risk of calf-to-calf trans-
mission is largely overlooked in the current JD prevention
and control programs. Furthermore, only 1 of 8 MAP mod-
eling studies included calf-to-calf transmission [15,16]. Even
though most reports only claim transmission between
adults and calves [17], recent reports suggest calves can be
infected by other calves [18,19]. These contradicting results
can be explained by the delayed onset of clinical disease
and the low sensitivity of diagnostic tests in the early stages
after MAP infection [8]. Van Roermund et al. reported that
calf-to-calf transmission occurred, and that contact with in-
fectious calves increased the possibility of other calves being
MAP-infected [19]. However, it is not known how often
and when these calves are shedding in relation to initialLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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studies determining how often infected calves shed MAP.
The objective of the current study was to determine
shedding patterns in calves inoculated with 2 doses of
MAP at 5 ages. Impact of age and dose at time of inocu-
lation on shedding patterns, as well as on interval to first
positive fecal culture, were assessed. Finally, the fre-
quency of fecal shedding was related to the severity of
tissue lesions in the same calves.
Materials and methods
Herds and calves
Study design and sample collection were described in detail
by Mortier et al. [20]. Briefly, male calves were collected
from low MAP prevalence herds (<5% seropositive
and < 5% fecal culture-positive) in Southern Alberta (Canada)
and included in the study when born in the presence of a
member of our research team. All dams were MAP ELISA
(IDEXX Paratuberculosis Ab Test; IDEXX Laboratories
Inc, Westbrook, ME, USA) and fecal culture-negative.
Upon arrival at the research facility, calves were fed
6 L of gamma-irradiated colostrum within 6 hours after
birth. The colostrum used in this study was collected
from ELISA-negative herds. This was followed by milk
replacer and calf starter grain (without antimicrobial ad-
ditives) and high-quality hay. Calves were individually
housed under stringent biosecurity conditions and no
contact was possible between calves. Calves were moni-
tored until 17 months of age (+ or – 2 weeks). Conse-
quently, calves inoculated at 2 weeks and 3, 6, 9, or
12 months were followed for 17, 14, 11, 8, and 5 months
after inoculation, respectively. Health status was monitored
on a daily basis by clinical inspection. At 17 months of age,
euthanasia and necropsies were performed, including
assessment for gross lesions, histology, and tissue culture
[20]. Animal care protocols M09083 and M09050 were
approved by the University of Calgary Animal Care
Committee.
Study design and inoculum
Study design and preparation of inoculum were de-
scribed by Mortier et al. [20]. Fifty calves were randomly
allocated to 5 age groups (2 weeks, 3, 6, 9 and
12 months). Six calves housed in the same conditions
were not inoculated (negative controls). In each of the 5
age groups, 5 calves were inoculated per os with a high
dose (HD) of MAP and 5 calves were inoculated with a
low dose (LD) of MAP. Because of logistics, this experi-
ment was performed in 2 replicates. The first and
second replicates included 33 and 23 calves, respectively,
with all age and dose groups represented in both
replicates.
A virulent cattle type MAP strain isolated from a clin-
ical Alberta JD case (Cow 69) was used for inoculation.This isolate had an identical BamHI, PvuII and PstI
IS900 – RFLP profile as the reference strain K10 recom-
mended for use in infection trials [21]. Calves were chal-
lenged on 2 consecutive days, with either 5 × 109 CFU
(HD) or 5 × 107 CFU (LD). The inoculum was prepared
and cultured in 7H9 broth and quantified using the pel-
leted wet weight method. The quantification was con-
firmed using an in-house quantitative realtime PCR with
a standard curve based on the 16S rRNA gene of Myco-
bacterium smegmatis, confirming the presence and the
quantity of the 16S rRNA gene using primers p882
(5′-aggattagataccctggtag-3′) and p1100 (5′-gctgacgacatc-
catgc-3′).
Fecal sampling and culture
Fecal samples were collected from the rectum from each
calf prior to inoculation. Samples collected 1–5 days
after inoculation were pooled (maximum of 3 samples
per pool), containing samples from one calf collected
over several days; this was an additional quality control
measure to ensure viability of the inoculum, sensitivity
of the fecal culture, and to confirm passive shedding of
MAP [21,22].
For the first 4 weeks after inoculation, rectal fecal sam-
ples were collected weekly; thereafter, fecal samples were
collected monthly. To ensure age-matched control sam-
ples for each inoculation group, control calves were sam-
pled twice per month.
All samples were processed using a modified TREK
ESP II liquid culture system (TREK para-JEM®; TREK
Diagnostic Systems, Cleveland, OH, USA) with subse-
quent IS900 PCR on all samples. In more detail: From
each fecal sample, 2 g was added to distilled water,
mixed and allowed to settle for 30 min. Fecal samples
were decontaminated according to manufacturer’s in-
structions. First, 5 mL of the settled mixture was added
to 25 mL of a 0.9% hexadecylpyridinium chloride (HPC)
in half strength brain heart infusion (BHI) solution and
incubated overnight. Then, samples were centrifuged for
20 min at 3000 × g. The supernatant was discarded and the
pellet was resuspended with a mixture of AS (ParaJem),
water and full strength BHI. Tubes were incubated again
for 24 h at 37 °C and added to the liquid culture medium
(TREK para-JEM®; TREK Diagnostic Systems, Cleveland,
OH, USA). After incubation for 48 days, MAP presence
was confirmed by conventional PCR on culture medium
targeting the IS900 region. Extraction of DNA was done as
described [23]. The IS900 PCR procedure was modified
from Vary et al. [24]; 5 μL of lysate was added to the
described reaction mixture, containing 1.25 U Top Taq
(Qiagen, Germantown, MD, USA), resulting in a reac-
tion volume of 50 μL. Culture followed by PCR results
were considered as a dichotomous outcome (MAP de-
tected/not detected).
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All statistical analyses were performed using STATA
11 (StataCorpLP, College Station, TX, USA), with a
P-value < 0.10 considered significant.
To distinguish between frequent shedding calves and
sporadic shedding calves, categories were assigned based
on the observed data: 0 = non-shedding calves, 1 = calves
shedding 1–4 times during the follow-up, and 2 = calves
shedding > 4 times during the follow-up period. Gross
lesions, microscopic lesions and tissue culture results at
necropsy were assigned to categories as described [20].
Differences in shedding between HD and LD calves,
between age at inoculation, and among months after
inoculation over time, as well as distributions of macro-
scopic and microscopic lesions and tissue culture results,
between fecal shedding groups, were evaluated using
Chi-square and Fisher’s Exact tests. Interval from inocu-
lation to the first positive fecal culture was plotted using
a Kaplan-Meier graph; groups were compared using the
logrank test of equality [25].
Results
Sporadic and frequent shedding
All pre-inoculation fecal samples were MAP culture-
negative. Passive shedding was detected 1–5 days after
inoculation. No calf was fecal culture-positive at 7 days
after inoculation and as of 2 weeks after inoculation,
shedding was considered active. All calves tested nega-
tive at 2 weeks after inoculation, except for Calf 4 inocu-
lated at 2 weeks of age with a HD, which started
shedding 2 weeks after inoculation (Figure 1). Two
calves (4 and 5; Figure 1) from the 2-week-HD group de-
veloped clinical JD; these calves consistently remained
fecal culture-positive until they were euthanized (due to
animal welfare concerns) at 16 months after inoculation
(Figure 1).
In the control group that was followed until 17 months
of age, 1 of 6 calves had 3 positive fecal cultures at 3.5, 4
and 7 months of age.
Shedding was detected at least once during the entire
follow-up period in 32 (64%) of the 50 MAP-inoculated
calves (Table 1, Figure 1) and occurred mostly sporadic-
ally in the shedding calves, with the exception of 4 calves
that shed at most samplings Calves 3, 4, 5 and 11;
Figure 1).
Impact of months after inoculation, dose, and age
Shedding peaked between inoculation and 6 months
after inoculation, with the highest proportion (40%, 20
calves of 50) of calves shedding at 2 months after inocu-
lation (P = 0.006; Figure 2).
Calves inoculated with a HD more frequently shed
more than 4 times compared to calves inoculated with a
LD (Figure 2) when inoculated at 2 weeks or 3 monthsof age (P = 0.04; Figure 2). Furthermore, all calves that
shed more than 4 times were inoculated with a HD of
MAP and at 2 weeks or 3 months of age. In groups inoc-
ulated at 6, 9, or 12 months of age, the proportion of
calves that shed at least once was equal to non-shedding
calves in those inoculated with either a HD or a LD of
MAP (P = 1.00; Figure 1). Furthermore, in none of these
groups did calves shed more than 4 times.
Association between frequency of shedding and necropsy
observations
Overall, the distribution of tissue culture categories and
gross lesion scores was not different between shedding
and non-shedding calves (P = 0.90 and 0.19, respectively;
Table 2). However, shedding calves had a higher histology
score than non-shedding calves (P = 0.08). Conversely,
when shedding frequency was taken into account, calves
having > 4 fecal culture-positive samplings between in-
oculation and necropsy had more culture-positive tis-
sue locations and more severe gross and histological
lesions compared to less frequent shedders (P = 0.03,
0.013 and < 0.001, respectively).
Interval inoculation to shedding
Interval to first positive fecal culture was not different
between the HD and LD calves (P = 0.25); however, the
interval between inoculation and first positive fecal cul-
ture increased with increasing age (P = 0.07; Figure 3).
Discussion
Calves in all 5 age groups and both dose groups shed
MAP in their feces, and sporadic, intermittent as well as
continuous shedding was detected. Calves inoculated at
a young age with a HD shed MAP more frequently than
LD calves. However, in older age groups (6, 9 and
12 months), this dose-dependent effect was no longer
present. Although shedding usually started within
6 months after inoculation (and peaked at 2 months),
calves inoculated at an older age usually started shed-
ding later after inoculation. Finally, frequently shedding
calves had more severe gross and histological lesions
and more MAP culture-positive tissue locations.
Even though older calves are still susceptible to MAP
infection [20], calves inoculated up to 3 months old in
particular shed MAP more frequently, especially when
inoculated with a HD of MAP. This was consistent with
previous reports that when calves are exposed at a young
age in particular to a HD of MAP, shedding and clinical
signs of JD will develop sooner after infection [19,26,27].
However, it is unclear why this dose difference disap-
peared when calves were inoculated at 6, 9 or 12 months
of age. Although infection under field conditions is un-
known, infection pressure on a farm regularly having
clinical JD cases is likely higher than a farm with only
Figure 1 Fecal culture results for individual calves per age and dose group. A solid filled box indicates a positive fecal culture, a white box
a negative culture and a box with a cross a missing sample. G = gross lesions, H = histology, and T = tissue culture at necropsy, boxes with
shading indicate a positive sample. * = this calf developed clinical signs of JD.
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farms shed more often compared to heifers on low-
prevalence farms [26]. Two doses of inoculum were
used, a HD of 5 × 109 CFU given on 2 consecutive days
(5 times the recommended standard bovine challenge
dose [21]) and a LD of 5 × 107 CFU also given on 2 con-
secutive days (10 times higher than the lowest confirmedTable 1 Number and percentage of shedding calves in 5 age
2 weeks 3 months 6 mont
Low dose 4* (80%) 4 (80%) 4 (80%)
High dose 5 (100%) 4 (80%) 3 (60%)
Total 9 (90%) 8 (80%) 7 (70%)
*5 calves total in each group; 50 calves in total.and consistent infectious dose for young calves [28]).
Even though a controlled infection trial cannot deter-
mine the bacterial burden on farm, we inferred that
these two doses represented realistic infection pressures
under field conditions. Calves inoculated at 2 weeks or
3 months with a HD of MAP shed more frequently,
had more severe gross and histology lesions and moreand 2 dose groups
hs 9 months 12 months Total
2 (40%) 1(20%) 15 (60%)
1 (20%) 4 (80%) 17 (68%)
3 (30%) 5 (50%)
Figure 2 Percentage fecal culture-positive calves in the 2 dose groups for every month after inoculation. A) calves inoculated at 2 weeks or
3 months of age, and B) calves inoculated at 6, 9 or 12 months of age. Solid dark bars represent calves inoculated with a high dose of MAP and open
white bars represent calves inoculated with a low dose of MAP. Note: the number of calves used to calculate this proportion decreases as the time after
inoculation increases (calves inoculated at 2 weeks or 3, 6, 9 or 12 months were followed for 17, 14, 11, 8 and 5 months after inoculation, respectively).
Table 2 Fecal culture results compared to tissue culture,
histology and macroscopy determined at necropsy
Fecal
culture1
Tissue culture2 Histology3 Macroscopy4
0 1 2 3 0 1 2 3 0 1 2 3 4
0 8† 9 1 0 6 11 1 0 10 0 2 8 0
1-4 13 13 1 0 2 24 1 0 9 4 0 12 0
> 4 1 1 1 2* 0 1 2 2* 0 0 0 3 2*
†Number of calves assigned to each category; 50 in total. Calves in total were
experimentally inoculated with MAP.
1Number of fecal culture-positive samplings starting 2 weeks after inoculation
until necropsy.
20 = no tissue locations culture-positive; 1 = 1–3 tissue locations culture-
positive; 2 = 4–6 tissue locations culture-positive; 3 = > 6
tissues culture-positive.
30 = no lesions; 1 = focal lesions; 2 = multifocal lesions; 3 = diffuse lymphocytic,
multibacillary or intermediate lesions.
40 = no macroscopic changes; 1 = one enlarged or edematous lymph node of
the small intestine or liver; 2 = multiple enlarged and edematous mesenteric
lymph nodes and/or hyperemia of the ileocaecal valve; 3 = enlarged
mesenteric lymph node(s) and/or mild to moderate thickening of ileal or
jejunal mucosa; 4 = enlarged mesenteric lymph node(s) and severe thickening
and corrugation of the ileal, jejunal and colon mucosa.
*These 2 calves had clinical signs of JD and were euthanized at 16 months
of age.
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of infection of young calves, in combination with lower-
ing the infection pressure, remains an essential compo-
nent of JD control programs.
Based on the general assumption that only younger
calves are susceptible to MAP infection [27], older calves
are rarely included in MAP challenge experiments [18].
However, in this experiment, it was noteworthy that
calves inoculated at 6, 9, or 12 months became infected
[20], and 40% shed early (at 1 and 2 months after inocu-
lation; Figure 1) after inoculation. Although this appar-
ent lack of dose dependency in the 6-, 9- and 12-month
inoculation groups was not expected a priori, suscepti-
bility of calves up to at least 1 year of age, even with a
low dose of MAP, should be considered in control
programs.
Shedding was most frequent in the first 6 months after
inoculation and peaked 2 months after inoculation. A
meta-analysis of MAP challenge experiments concluded
that the median time to first shedding was 3 months,
whereas most shedding was detected within 6 months
after inoculation [18]. Other studies documenting early
shedding that were not included in that meta-analysis
Figure 3 Kaplan-Meier curve for time to first positive fecal sample. A) per age group, and B) per dose group. Proportion of calves not
having shed yet are plotted for each month after inoculation; each curve represents all 10 calves each of the 5 age groups or all 25 calves in
each dose group in A) and B), respectively.
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after oral inoculation in 4 calves receiving an oral dose
of 1011-1012 CFU of MAP [29] and in 20 calves inocu-
lated orally with 108 CFU of MAP [30]. The peak in
shedding probably depends on the dose of inoculation;
in calves inoculated with a HD of MAP, the peak oc-
curred sooner after inoculation [19]. Additionally, in a
clinical trial involving 56 calves, this shedding peak was
not reduced after Hsp70 vaccination, even though the
candidate vaccine reduced shedding after this initial
peak [31]. A peak in shedding shortly after inoculation
also occurred in 4 white-tailed deer inoculated with an
oral dose of 1010 CFU of MAP [32] and in a vaccinationtrial including 16 goats orally inoculated with 109 CFU
of MAP [33]. Early shedding was also observed in 38
orally inoculated sheep (dose 107-108 CFU) [34]. Also,
in a mouse model, a peak in fecal shedding occurred
4 months after inoculation, whereas only a low bacterial
burden was detected in intestinal tissues [35]. At 5 months
after inoculation, the number of bacteria in the tissues was
still increasing progressively [35]. An early peak in shedding
was in this case not consistent with the general assumption
that high shedding is associated with a higher bacterial bur-
den in the tissues. Clearly, there is an urgent need to eluci-
date mechanisms behind translocation of MAP to the
intestinal lumen and subsequent shedding in feces.
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is currently unknown [36]. This peak did not coincide
with age-related and developmental changes of the
calves, for example weaning, as this peak occurred in
all 5 inoculation age groups. Therefore, this peak was
more likely due to temporal changes in host cells con-
taining MAP. Previously, it was suggested that infected
macrophages will emigrate from the mucosa into the
intestinal lumen and consequently passed in the feces,
consistent with intermittent shedding [37,38]. Others
have theorized that shedding of MAP comes from burst
macrophages in the mucosa producing extracellular bac-
teria, and if these bacteria remain extracellular and translo-
cate to the lumen, this would explain increased shedding of
MAP in feces [39]. However, none of these hypotheses ex-
plain a peak in shedding within the first 6 months, rather
than a progressively increasing level of shedding through-
out MAP infection. Understanding this shedding mechan-
ism will likely explain this early peak in shedding.
Frequently shedding calves had more severe gross and
histological lesions, and more culture-positive tissue lo-
cations. Dissemination of MAP in multiple organs was
observed in high shedders [40,41], corresponding with
animals in a clinical stage of infection. Lesions at nec-
ropsy were more severe in calves that shed frequently.
Even though only 2 of the 5 frequently shedding calves
in this study had clinical signs, typically coinciding with
consistent shedding and severe necropsy lesions [8], we
expected that frequently shedding calves without clinical
signs also would have more positive tissue locations and
more severe gross and histological lesions. Additionally,
it was reported that MAP can disseminate before ap-
pearance of clinical signs [20,41] and cause positive tis-
sue cultures. This could account for frequently shedding
calves without clinical signs having more positive tissue
locations and more severe gross and histological lesions
compared to sporadically shedding calves. Presumably,
clinical signs would have subsequently appeared in these
frequently shedding calves if the study had not been
completed at 17 months of age.
One of 6 non-inoculated calves had 3 positive fecal
cultures (at 3.5, 4 and 7 months after inoculation) and
was also positive on histology, suggesting a true infec-
tion with MAP. Even though all calves in this study were
housed individually and strict biosecurity measures were
applied to avoid cross-contamination, MAP may have
been transferred from shedding calves to this control
calf. This control calf was not housed adjacent to one of
the calves that were shedding constantly, but calf-to-calf
transmission (via objects) could have occurred. Recently,
dust has also been suggested as a means of transmission
for MAP [42-45]. It is unlikely that the hay fed to the
calves was contaminated with MAP, because the hay was
harvested from fields not grazed by cattle for severalyears. In utero infection is a possibility [46], despite con-
siderable efforts to use calves with minimal probability
of an intrauterine infection. The MAP isolates recovered
from the infected calves were found to be the same
strain used for the inoculation. Based on whole-genome
sequencing of over 100 Canadian MAP isolates, the
inoculum strain belongs to a lineage that represents
approximately 6% of isolates in Canada differing in 200
single nucleotide polymorphisms (SNPs) from the near-
est lineage (Ahlstrom et al., unpublished). In addition,
PCR amplification of a genomic region, including one of
these lineage-specific SNPs (Ahlstrom et al., unpub-
lished) was done on positive fecal culture samples se-
lected from shedding calves representing all age and
dose groups in the experiment. All sequences recovered
from the fecal isolates shared the specific inoculum
lineage SNP; because only 6% of isolates found in Alberta
belong to this lineage, it can be concluded with confidence
that the isolates were derived from inoculum strain Cow69.
Unfortunately, this method was unsuccessful in amplifying
the genomic region around this SNP for the shedding con-
trol calf and gaining insight regarding the source of infec-
tion was not possible. Additionally, whole-genome
sequencing of MAP isolates recovered from the ileum
and ileocecal valve of Calf 5 were in full agreement
with the inoculum Cow69 genome.
Calves in the carrier/subclinical stage of JD may have
shed MAP at low levels [47] and since sensitivity of fecal
culture is relatively low (23 - 74%, depending on gold
standard and definition used) [48], some shedding might
have been missed in this study. Although more frequent
sampling (weekly, daily) might have increased the detec-
tion rate of MAP in feces, this would have been very
costly. Additionally, quantification of MAP was not done
because the levels of shedding were expected to be low
[47] in most calves; consequently, quantitative tech-
niques (e.g. direct qPCR) would not have provided much
additional information.
Even though passive shedding could be mistaken for
active shedding due to infection, there was no reason to
believe this was the case. In this experiment, passive
shedding was detected in the days immediately following
oral inoculation of MAP, although calves subsequently
tested negative 1 week after inoculation, consistent with
previous reports [21,22]. Therefore, shedding 2 weeks
after inoculation was considered active shedding, as sug-
gested [21].
In all MAP challenge experiments of younger calves
[18,19,31], a high proportion of calves shed the bacteria
relatively soon after infection. In this study, shedding
was detected over the entire period of 16 months. Due
to increased adoption of acidified milk feeding and auto-
matic milk feeders, many dairy calves are group-housed
both before and after weaning, with potential for calf-to-
Mortier et al. Veterinary Research 2014, 45:71 Page 8 of 9
http://www.veterinaryresearch.org/content/45/1/71calf transmission. Therefore, as a next step, an experi-
ment should be done in which inoculated calves are kept
in groups with non-infected calves to confirm whether
MAP is transferred between calves. Also, the presence of
shedding of young stock on dairy farms should be deter-
mined. If these 2 steps confirm calf-to-calf transmission,
JD control programs should be adjusted to include pre-
vention of calf-to-calf transmission of MAP.
When minimizing exposure of calves to manure, this
will benefit reduction of MAP-infection as well as reduc-
tion of other fecal-orally transmitted diseases [2,7]. Pre-
ventive measures for young calves should be extended to
calves up to 1 year of age (based on this trial). However,
naturally exposed heifers became infected [49], arguably all
age references should be removed from control programs,
because older calves are still susceptible to MAP infection
and shedding as a consequence. Reducing infection pres-
sure in general is important to keep the infection dose low
and thus reduce the effects of JD.
To conclude, calves inoculated with MAP up to 1 year
of age shed MAP shortly after inoculation, with a peak
2 months after inoculation. Some calves inoculated with
a HD shed continuously. This could result in contam-
ination of the environment of calves, and when group-
housed lead to calf-to-calf transmission. Prevention
programs may be more effective if calves up to 1 year of
age are considered both susceptible to MAP infection and a
potential source of infection for other calves.
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